- £228.50m
- £238.27m
- £139.99m
- 15
- 28
- 49
- 19
REG - Oxford Biomedica PLC - Non-Executive Director Appointment
AnnouncementRCS - Oxford Biomedica PLC - OXB and PhoreMost enter gene therapy collaboration
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Axovant update on AXO-Lenti-PD and virtual R&D day
AnnouncementREG - Oxford Biomedica PLC - Director Purchase
AnnouncementREG - Oxford Biomedica PLC Aviva PLC - Holding(s) in Company
AnnouncementREG - Oxford Biomedica PLC - Axovant update on 2nd cohort of SUNRISE-PD trial
AnnouncementREG - Oxford Biomedica PLC - OXB receives approval for fourth suite in Oxbox
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Director Dealings
AnnouncementREG - Oxford Biomedica PLC - Director/PDMR Shareholding
AnnouncementREG - Oxford Biomedica PLC - Director/PDMR Shareholding
AnnouncementREG - Oxford Biomedica PLC - Interim Results
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Master Supply and Development Agreement with AZ
AnnouncementREG - Oxford Biomedica PLC - Notice of Interim Results
AnnouncementREG - Oxford Biomedica PLC - Block listing Application
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - OXB signs DMLA with Beam Therapeutics
Announcement